Supplementary Figure S5 from Phase II Trial of Nivolumab in Metastatic Rare Cancer with Dmmr or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
openalex(2023)
Abstract
Supplementary Figure S5: T-BET and PD-1 expression on the CD8+ T cells at the base line (related with the main figure 3).
MoreTranslated text
Key words
T Cell Therapy,Tumor Regression,Tumor Microenvironment,T-cell Exhaustion,Biomarkers for Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined